STOCK TITAN

Dolby Laboratories (NYSE: DLB) SVP exercises options, sells 7,667 shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Dolby Laboratories SVP, Entertainment John D. Couling exercised employee stock options for 7667 shares of Class A common stock at an exercise price of $45.5000 and, on the same day, sold 783 shares at a weighted average price of $59.0343 and 6884 shares at $60.1075 pursuant to a Rule 10b5-1 trading plan. He continues to hold options for 15334 shares, and his holdings include 55,114 shares underlying restricted stock units that remain subject to vesting conditions.

Positive

  • None.

Negative

  • None.
Insider Couling John D
Role SVP, Entertainment
Sold 7,667 shs ($460K)
Approx. gross sale proceeds $460K
Approx. exercise cost $349K
Approx. pre-tax spread $111K
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) F4 7,667 $0.00 $0.00
Exercise Class A Common Stock F1 7,667 $45.50 $349K
Sale Class A Common Stock F2, F1 783 $59.0343 $46K
Sale Class A Common Stock F3, F1 6,884 $60.1075 $414K
Holdings After Transaction: Employee Stock Option (Right to Buy) — 15,334 shares (Direct); Class A Common Stock — 118,727 shares (Direct)
Footnotes (4)
  1. F1. Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
  2. F2. The shares were sold in multiple transactions at prices ranging from $58.89 to $59.46, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. F3. The shares were sold in multiple transactions at prices ranging from $59.895 to $60.385, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  4. F4. This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.
Options exercised 7667 shares Employee stock options for Class A common stock exercised on 2026-08-03
Exercise price $45.5000 per share Exercise price of employee stock option exercised for 7667 shares
Shares sold (block 1) 783 shares Class A common stock sold at weighted average $59.0343 on 2026-08-03
Sale price (block 1) $59.0343 per share Weighted average sale price; individual trades ranged $58.89–$59.46
Shares sold (block 2) 6884 shares Class A common stock sold at weighted average $60.1075 on 2026-08-03
Sale price (block 2) $60.1075 per share Weighted average sale price; individual trades ranged $59.895–$60.385
Options remaining 15334 shares Options for Class A common stock held directly after the exercise transaction
RSU underlying shares 55,114 shares Class A shares underlying restricted stock units, subject to forfeiture until vesting
Employee Stock Option (Right to Buy) financial
"security_title: Employee Stock Option (Right to Buy)"
restricted stock units financial
"shares of Class A common stock underlying restricted stock units, which are subject"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average sale price financial
"The price reported above reflects the weighted average sale price."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What transactions did John D. Couling report for Dolby (DLB)?

John D. Couling reported exercising 7667 stock options for Class A shares at $45.5000 and selling 7667 shares in two open-market transactions on the same day, all under a Rule 10b5-1 trading plan.

How many Dolby (DLB) options did John D. Couling exercise and at what price?

He exercised 7667 employee stock options for Dolby Class A common stock at an exercise price of $45.5000 per share. These options were part of an original grant covering 46,000 shares and were fully vested and exercisable on the transaction date.

How many Dolby (DLB) shares did John D. Couling sell and at what prices?

He sold a total of 7667 shares, including 783 shares at a weighted average price of $59.0343 and 6884 shares at $60.1075. Sale prices ranged from $58.89–$59.46 and $59.895–$60.385, respectively, across multiple transactions.

Were John D. Couling’s Dolby (DLB) trades made under a Rule 10b5-1 plan?

Yes. The filing affirms that the reported transactions were made under a Rule 10b5-1 trading plan, indicating they followed a pre-established contract or instruction designed to satisfy Rule 10b5-1(c) affirmative defense conditions.

What Dolby (DLB) equity awards does John D. Couling hold after these transactions?

After the reported trades, he continues to hold options for 15334 shares of Class A common stock. His holdings also include 55,114 shares underlying restricted stock units, which are subject to forfeiture until they vest.

What was the size of the original Dolby (DLB) option grant exercised in this Form 4?

The exercised option was originally granted for 46,000 shares of Dolby Class A common stock. In this transaction, only 7667 shares were exercised; the option was already fully vested and exercisable on the transaction date.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Couling John D

(Last)(First)(Middle)
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET

(Street)
SAN FRANCISCO CALIFORNIA 94103

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, Entertainment
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock08/03/2026M7,667A$45.5126,394(1)D
Class A Common Stock08/03/2026S783D$59.0343(2)125,611(1)D
Class A Common Stock08/03/2026S6,884D$60.1075(3)118,727(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$45.508/03/2026M7,667 (4)12/15/2026Class A Common Stock7,667$015,334D
Explanation of Responses:
1. Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
2. The shares were sold in multiple transactions at prices ranging from $58.89 to $59.46, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
3. The shares were sold in multiple transactions at prices ranging from $59.895 to $60.385, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
4. This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.
/s/ Daniel Rodriguez as Attorney-in-Fact for John Couling08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)